Eleni Kotsiliti
Eleni Kotsiliti
Eleni Kotsiliti
Eleni Kotsiliti
Diet-microbiome associations [0.03%]
Eleni Kotsiliti
Eleni Kotsiliti
Eleni Kotsiliti
Eleni Kotsiliti
Beyond class effects: moving towards drug-level precision in inflammatory bowel disease therapy [0.03%]
Sailish Honap,Vipul Jairath,Fernando Magro et al.
Sailish Honap et al.
Yong Ding,Zhiwei Zhang,Kai Wang et al.
Yong Ding et al.
The microbiome is widely involved in host metabolism, with many omics studies suggesting that it is important for metabolic health. Although studies in this area have made great strides in furthering our understanding of the role of the mic...
Shilpa Chokshi,Ashwin Dhanda,Matthew E Cramp et al.
Shilpa Chokshi et al.
Human liver tissue has been found to contain microplastics and nanoplastics (MNPs), with evidence that hepatic MNP accumulation has markedly increased over the past 10 years, prompting critical questions regarding their potential causal rol...
Clemens Neufert,Markus F Neurath
Clemens Neufert
Colitis-associated colorectal cancer (caCRC) is a subset of lower gastrointestinal tract malignancies that occurs in patients with inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn's disease. The global prevalence of IB...
Artificial intelligence in inflammatory bowel disease: bridging innovation, implementation and impact [0.03%]
人工智能在炎症性肠病中的应用：连接创新、实施和影响
Marietta Iacucci,Giovanni Santacroce,Yasuharu Maeda et al.
Marietta Iacucci et al.
Artificial intelligence (AI) is rapidly transforming the management landscape of inflammatory bowel disease (IBD). While early applications in endoscopy, digital pathology and cross-sectional imaging drew substantial attention, next-generat...
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management [0.03%]
与代谢紊乱相关的非酒精性脂肪肝炎的治疗靶点——个性化疾病管理方法
Mary E Rinella,Silvia Sookoian
Mary E Rinella
Metabolic dysfunction-associated steatotic liver disease (MASLD), a leading global cause of chronic liver disease, encompasses a wide spectrum of disease stages from isolated hepatic steatosis to cirrhosis. After decades of limited therapeu...